What RADNOSTIX, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Atcher Robert | Director | Oct 10 | Grant / award · A | +250,000 | — | — | 1,000,000 |
| Bagerdjian Shahe | Pres. & CEO | May 22 | Open-market buy · P | +140,000 | $0.05 | +$7K | 9,026,999 |
| Bagerdjian Shahe | Pres. & CEO | Apr 24 | Withheld — tax / exercise cost · F | −583,229 | $0.05 | −$29.2K | 8,886,999 |
| Bagerdjian Shahe | Pres. & CEO | Mar 06 | Open-market buy · P | +177,000 | $0.05 | +$8.85K | 9,570,228 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +230,769 | — | — | 11,681,898 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +40,384 | — | — | 365,550 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +40,384 | — | — | 365,550 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +269,999 | — | — | 38,477,083 |
| Cox W Matthew | Chief Financial Officer | Nov 22 | Open-market buy · P | +60,000 | $0.03 | +$1.8K | 897,736 |
| Cox W Matthew | Chief Financial Officer | Nov 20 | Open-market buy · P | +30,000 | $0.04 | +$1.2K | 837,736 |
| Bagerdjian Shahe | Pres. & CEO | Nov 20 | Open-market buy · P | +100,000 | $0.04 | +$4K | 9,393,228 |
| Grosso Christopher G | Director | Nov 14 | Open-market buy · P | +401,117 | $0.03 | +$12K | 1,026,283 |
| Grosso Christopher G | Director | Sep 18 | Open-market buy · P | +300,000 | $0.03 | +$9K | 625,166 |
| Grosso Christopher G | Director | Sep 18 | Open-market buy · P | +500,000 | $0.03 | +$15K | 38,707,084 |
| Bagerdjian Shahe | Pres. & CEO | Sep 13 | Grant / award · A | +350,000 | — | — | 9,293,228 |
| Cox W Matthew | Chief Financial Officer | Jun 14 | Open-market buy · P | +239,669 | $0.04 | +$9.59K | 807,736 |
| Bagerdjian Shahe | Pres. & CEO | Jun 14 | Open-market buy · P | +250,000 | $0.04 | +$10K | 8,943,228 |
| Bagerdjian Shahe | Pres. & CEO | Apr 17 | Withheld — tax / exercise cost · F | −531,750 | $0.04 | −$21.3K | 8,693,228 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +240,000 | — | — | 11,451,129 |
| Grosso Christopher G | Director | Feb 17 | Other Transaction · J | +42,000 | — | — | 325,166 |
Loading...
